Gene expression profiling in a validation cohort of locally advanced and recurrent/metastatic salivary gland cancers
Conditions: Salivary Gland Cancer Interventions: Other: Observation Sponsors: Royal Marsden NHS Foundation Trust Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 19, 2023 Category: Research Source Type: clinical trials

Phase II Trial of Sacituzumab Govitecan in Recurrent and/or Metastatic Salivary Gland Cancers
Conditions:   Gland;   Salivary Gland Cancers Intervention:   Drug: Sacituzumab Govitecan Sponsors:   M.D. Anderson Cancer Center;   Gilead Sciences Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 1, 2023 Category: Research Source Type: clinical trials

Testing the Anti-Cancer Drug Darolutamide in Patients With Testosterone-driven Salivary Gland Cancers
Conditions:   Locally Advanced Salivary Gland Carcinoma;   Metastatic Salivary Gland Carcinoma;   Recurrent Salivary Gland Carcinoma;   Unresectable Salivary Gland Carcinoma Interventions:   Procedure: Biopsy;   Procedure: Biospecimen Collection;   Drug: Darolutamide;   Drug: Leuprolide Acetate Sponsor:   National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 3, 2023 Category: Research Source Type: clinical trials